Wellmarker Bio

Developer of biomarker-based therapeutics for the treatment of cancer

placeSeoul, Seoul, South Korea calendar_todayFounded 2016 groups58 employees language wmbio.co

Registered entities

Investor mix

21 investors on record; lead investors include Orbit Partners, bric-investment.com, NH Investment & Securities, Cytogen.

Investor typeCountShare
Venture capital733%
Private equity314%
Accelerator & incubator210%
Bank & private debt210%
Other / undisclosed733%
Coming soon